Established in September 2011, Korea Drug Development Fund (KDDF) is a government-initiated drug development program. It aims to transform Korea into the global leader for new drug development. It has a budget of 1 billion US dollars to enhance national competitiveness in the global arena. KDDF is now backed by three health-related Korean ministries: the Ministry of Science, ICT, and Future Planning, the Ministry of Trade, Industry, and Energy, and the Ministry of Health and Welfare. KDDF aims to enhance development of at least 10 new global blockbuster drugs by the year 2020.
Company Details
- Employees
- 13
- Founded
- -
- Address
- Uspace2 A-502, Sampyeong-Dong, Bundang-Gu, Seongnam-Si,gyeonggi-Do 13494,korea, Republic Of
- Phone
- +82-2-712-3396
- kd****@****ddf.org
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- kddf.org
- HQ
- Seongnam-si, Gyeonggi-do
Korea Drug Development Fund Questions
Korea Drug Development Fund's helpline number is +82-2-712-3396
Korea Drug Development Fund's website is kddf.org
Korea Drug Development Fund's LinkedIn profile is https://kr.linkedin.com/company/korea-drug-development-fund
Korea Drug Development Fund has
13 employees.
View email and phone details for 13
employees at Korea Drug Development Fund.
Korea Drug Development Fund's industry is
Pharmaceutical Manufacturing
Korea Drug Development Fund's top competitors are
Bioplus-Interphex Korea,
Sk Life Science, Inc.,
Medytox,
International Pediatric Nephrology Association (Ipna),
Modgut,
Korea Drug Development Fund (Kddf),
보령제약,
International Society For Hemodialysis,
Ibody Inc.,
바이오미래식품산업협의회 (Bffic).
Korea Drug Development Fund's support email address is kddf@kddf.org
Korea Drug Development Fund's categories are Pharmaceutical Manufacturing
Korea Drug Development Fund's founding year is 2011
